{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:31Z","timestamp":1787009011702,"version":"build-2736575974"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T00:00:00Z","timestamp":1367971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Treg cells endowed with enhanced killing activity through decoration with Fas-ligand (FasL) protein (killer Treg) have been effective in delay of hyperglycemia in prediabetic non-obese diabetic (NOD) mice. In this study, we assessed the therapeutic efficacy of these cells, harvested from age-matched euglycemic NOD donors, on the course of disease in new-onset diabetics. One dose of 4 \u00d7 106 killer Treg cells stabilized blood glucose associated with increased insulin levels in 5 of 9 mice and partially reversed the severity of islet inflammation, whereas naive Treg cells did not modulate the course of disease significantly. Killer Treg cells were shown to operate through induction of cell apoptosis within the pancreatic lymph nodes, resulting in reduced efficiency of adoptive disease transfer to NOD\/SCID recipients. A second mechanism of action consisted of increased fractions of CD4+CD25\u2212FoxP3+ T cells in the pancreas and all lymphoid organs. Immunomodulation with FasL rather than Treg cells enhanced the expression of CD25 and FoxP3 in the thymus, suggesting a possible contribution of thymic output to prolonged stabilization of the glucose levels. Autologous Treg cells evolve as excellent vehicles for targeted delivery of FasL as an immunomodulatory protein, which delete pathogenic cells at the site of inflammation and induce systemic dominance of suppressor subsets.<\/jats:p>","DOI":"10.1093\/intimm\/dxt016","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T23:53:35Z","timestamp":1368057215000},"page":"485-494","source":"Crossref","is-referenced-by-count":15,"title":["Killer Treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation"],"prefix":"10.1093","volume":"25","author":[{"given":"Ayelet","family":"Kaminitz","sequence":"first","affiliation":[{"name":"Frankel Laboratory, Center for Stem Cell Research, Schneider Children\u2019s Medical Center of Israel 1 , Petach Tikva 49202 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma S.","family":"Yolcu","sequence":"additional","affiliation":[{"name":"Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville 2 , Louisville, KY 40202 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Mizrahi","sequence":"additional","affiliation":[{"name":"Frankel Laboratory, Center for Stem Cell Research, Schneider Children\u2019s Medical Center of Israel 1 , Petach Tikva 49202 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haval","family":"Shirwan","sequence":"additional","affiliation":[{"name":"Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville 2 , Louisville, KY 40202 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadir","family":"Askenasy","sequence":"additional","affiliation":[{"name":"Frankel Laboratory, Center for Stem Cell Research, Schneider Children\u2019s Medical Center of Israel 1 , Petach Tikva 49202 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,5,8]]},"reference":[{"key":"2022073001193289800_CIT0001","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/08830180590934994","article-title":"Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse","volume":"24","author":"Chatenoud","year":"2005","journal-title":"Int. Rev. Immunol"},{"key":"2022073001193289800_CIT0002","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-2008-1042427","article-title":"Role of regulatory T cells for the treatment of type 1 diabetes mellitus","volume":"40","author":"Jaeckel","year":"2008","journal-title":"Horm. Metab. Res"},{"key":"2022073001193289800_CIT0003","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/dmrr.945","article-title":"Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease","volume":"25","author":"Sgouroudis","year":"2009","journal-title":"Diabetes Metab. Res. Rev"},{"key":"2022073001193289800_CIT0004","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.158.6.2947","article-title":"CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice","volume":"158","author":"Chatenoud","year":"1997","journal-title":"J. Immunol"},{"key":"2022073001193289800_CIT0005","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1073\/pnas.1533365100","article-title":"In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro","volume":"100","author":"Klein","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"2022073001193289800_CIT0006","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/diabetes.54.2.306","article-title":"Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes","volume":"54","author":"Jaeckel","year":"2005","journal-title":"Diabetes"},{"key":"2022073001193289800_CIT0007","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1180","article-title":"Mechanisms of suppression by suppressor T cells","volume":"6","author":"von Boehmer","year":"2005","journal-title":"Nat. Immunol"},{"key":"2022073001193289800_CIT0008","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.autrev.2008.03.001","article-title":"Mechanisms of T regulatory cell function","volume":"7","author":"Askenasy","year":"2008","journal-title":"Autoimmun. Rev"},{"key":"2022073001193289800_CIT0009","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int. Immunol"},{"key":"2022073001193289800_CIT0010","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"2022073001193289800_CIT0011","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol"},{"key":"2022073001193289800_CIT0012","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","article-title":"Human T regulatory cells can use the perforin pathway to cause autologous target cell death","volume":"21","author":"Grossman","year":"2004","journal-title":"Immunity"},{"issue":"Suppl 1","key":"2022073001193289800_CIT0013","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1111\/j.1365-2567.2008.02961.x","article-title":"Human CD4low CD25high regulatory T cells indiscriminately kill autologous activated T cells","volume":"128","author":"Bryl","year":"2009","journal-title":"Immunology"},{"key":"2022073001193289800_CIT0014","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.4049\/jimmunol.171.9.4604","article-title":"CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner","volume":"171","author":"Janssens","year":"2003","journal-title":"J. Immunol"},{"key":"2022073001193289800_CIT0015","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.4049\/jimmunol.176.8.4730","article-title":"Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo","volume":"176","author":"Weber","year":"2006","journal-title":"J. Immunol"},{"key":"2022073001193289800_CIT0016","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/icb.2008.62","article-title":"Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression","volume":"86","author":"Yolcu","year":"2008","journal-title":"Immunol. Cell Biol"},{"key":"2022073001193289800_CIT0017","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.icb.7100093","article-title":"The vicious cycle of apoptotic beta-cell death in type 1 diabetes","volume":"85","author":"Kaminitz","year":"2007","journal-title":"Immunol. Cell Biol"},{"key":"2022073001193289800_CIT0018","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nri2192","article-title":"Type 1 diabetes as a relapsing-remitting disease?","volume":"7","author":"von Herrath","year":"2007","journal-title":"Nat. Rev. Immunol"},{"key":"2022073001193289800_CIT0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaut.2009.07.001","article-title":"Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice","volume":"33","author":"Kaminitz","year":"2009","journal-title":"J. Autoimmun"},{"key":"2022073001193289800_CIT0020","doi-asserted-by":"crossref","first-page":"e21630","DOI":"10.1371\/journal.pone.0021630","article-title":"Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice","volume":"6","author":"Kaminitz","year":"2011","journal-title":"PLoS One"},{"key":"2022073001193289800_CIT0021","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.molimm.2007.01.014","article-title":"A novel multimeric form of FasL modulates the ability of diabetogenic T cells to mediate type 1 diabetes in an adoptive transfer model","volume":"44","author":"Franke","year":"2007","journal-title":"Mol. Immunol"},{"key":"2022073001193289800_CIT0022","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2011.03.003","article-title":"Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice","volume":"37","author":"Kaminitz","year":"2011","journal-title":"J. Autoimmun"},{"key":"2022073001193289800_CIT0023","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaut.2010.06.002","article-title":"Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells","volume":"35","author":"Kaminitz","year":"2010","journal-title":"J. Autoimmun"},{"key":"2022073001193289800_CIT0024","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00125-009-1604-4","article-title":"Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice","volume":"53","author":"Yarkoni","year":"2010","journal-title":"Diabetologia"},{"key":"2022073001193289800_CIT0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbmt.2011.11.016","article-title":"IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy","volume":"18","author":"Yarkoni","year":"2012","journal-title":"Biol. Blood Marrow Transplant"},{"key":"2022073001193289800_CIT0026","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/scd.2011.0057","article-title":"Elutriated stem cells derived from the adult bone marrow differentiate into insulin-producing cells in vivo and reverse chemical diabetes","volume":"21","author":"Iskovich","year":"2012","journal-title":"Stem Cells Dev"},{"key":"2022073001193289800_CIT0027","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1182\/blood-2004-06-2364","article-title":"Induction of tolerance using Fas ligand: a double-edged immunomodulator","volume":"105","author":"Askenasy","year":"2005","journal-title":"Blood"},{"key":"2022073001193289800_CIT0028","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.4049\/jimmunol.181.7.4516","article-title":"Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo","volume":"181","author":"Tonkin","year":"2008","journal-title":"J. Immunol"},{"key":"2022073001193289800_CIT0029","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2337\/db10-0630","article-title":"Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential","volume":"59","author":"Peakman","year":"2010","journal-title":"Diabetes"},{"key":"2022073001193289800_CIT0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaut.2009.09.002","article-title":"Consideration of strategies for hematopoietic cell transplantation","volume":"33","author":"Yaniv","year":"2009","journal-title":"J. Autoimmun"},{"key":"2022073001193289800_CIT0031","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2010.05.019","article-title":"Does lymphopenia preclude restoration of immune homeostasis? The particular case of type 1 diabetes","volume":"9","author":"Askenasy","year":"2010","journal-title":"Autoimmun. Rev"},{"key":"2022073001193289800_CIT0032","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.autrev.2006.02.005","article-title":"Does physiological beta cell turnover initiate autoimmune diabetes in the regional lymph nodes?","volume":"5","author":"Pearl-Yafe","year":"2006","journal-title":"Autoimmun. Rev"},{"key":"2022073001193289800_CIT0033","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2012-304432","article-title":"Immunomodulation with regulatory T cells and Fas-ligand ameliorate established inflammatory colitis","author":"Kaminitz","year":"2013","journal-title":"Gut"},{"key":"2022073001193289800_CIT0034","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1073\/pnas.0408679102","article-title":"Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion","volume":"102","author":"Zelenay","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"2022073001193289800_CIT0035","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1073\/pnas.0811556106","article-title":"Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity","volume":"106","author":"Komatsu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"2022073001193289800_CIT0036","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.4049\/jimmunol.165.6.3105","article-title":"CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations","volume":"165","author":"Stephens","year":"2000","journal-title":"J. Immunol"},{"key":"2022073001193289800_CIT0037","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ni743","article-title":"Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo","volume":"3","author":"Gavin","year":"2002","journal-title":"Nat. Immunol"},{"key":"2022073001193289800_CIT0038","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","article-title":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3","volume":"22","author":"Fontenot","year":"2005","journal-title":"Immunity"},{"key":"2022073001193289800_CIT0039","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol"},{"key":"2022073001193289800_CIT0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-3083.2009.02268.x","article-title":"CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2","volume":"70","author":"Pedersen","year":"2009","journal-title":"Scand. J. Immunol"},{"key":"2022073001193289800_CIT0041","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med"},{"key":"2022073001193289800_CIT0042","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.4049\/jimmunol.173.12.7259","article-title":"CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion","volume":"173","author":"Curotto de Lafaille","year":"2004","journal-title":"J. Immunol"},{"key":"2022073001193289800_CIT0043","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1084\/jem.20041201","article-title":"Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus","volume":"201","author":"Liang","year":"2005","journal-title":"J. Exp. Med"},{"key":"2022073001193289800_CIT0044","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","article-title":"Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction","volume":"28","author":"Tang","year":"2008","journal-title":"Immunity"},{"key":"2022073001193289800_CIT0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.20030422","article-title":"Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells","volume":"198","author":"Yamazaki","year":"2003","journal-title":"J. Exp. Med"},{"key":"2022073001193289800_CIT0046","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J. Exp. Med"},{"key":"2022073001193289800_CIT0047","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20040180","article-title":"CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes","volume":"199","author":"Tarbell","year":"2004","journal-title":"J. Exp. Med"},{"key":"2022073001193289800_CIT0048","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2004.11.004","article-title":"CD4+CD25 high regulatory T cells in human autoimmune diabetes","volume":"24","author":"Putnam","year":"2005","journal-title":"J. Autoimmun"},{"key":"2022073001193289800_CIT0049","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/157488807782793754","article-title":"Participation of adult bone marrow-derived stem cells in pancreatic regeneration: neogenesis versus endogenesis","volume":"2","author":"Iskovich","year":"2007","journal-title":"Curr. Stem Cell Res. Ther"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/25\/8\/485\/45192734\/intimm_25_8_485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/25\/8\/485\/45192734\/intimm_25_8_485.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T12:02:25Z","timestamp":1688212945000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article\/25\/8\/485\/686877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,8]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,5,8]]},"published-print":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxt016","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,8]]},"published":{"date-parts":[[2013,5,8]]}}}